Browse > Article
http://dx.doi.org/10.3904/kjm.2012.82.6.774

A Case of May-Thurner Syndrome with Systemic Lupus Erythematosus in Antiphospholipid Syndrome  

Kim, Ji-Hun (Department of Internal Medicine, Kyungpook National University School of Medicine)
Kang, Jong-Wan (Department of Internal Medicine, Kyungpook National University School of Medicine)
Bae, Gi-Bum (Department of Internal Medicine, Kyungpook National University School of Medicine)
Lee, Jong-Min (Department of Radiology, Kyungpook National University School of Medicine)
Im, Churl-Hyun (Department of Internal Medicine, Kyungpook National University School of Medicine)
Nam, Eon-Jeong (Department of Internal Medicine, Kyungpook National University School of Medicine)
Kang, Young-Mo (Department of Internal Medicine, Kyungpook National University School of Medicine)
Publication Information
The Korean Journal of Medicine / v.82, no.6, 2012 , pp. 774-777 More about this Journal
Abstract
May-Thurner syndrome, which refers to an iliofemoral venous thrombosis caused by chronic compression of the left common iliac vein by the right common iliac artery, usually manifests as left lower extremity pain and swelling. The syndrome is particularly evident in patients with health conditions including obesity, smoking, pregnancy, surgery, or prolonged immobility. Antiphospholipid syndrome consists of arterial or venous thrombosis and the association of lupus anticoagulant or anticardiolipin antibodies. Most common clinical manifestations include pregnancy loss and deep vein thrombosis. We experienced a rare case of May-Thurner syndrome concurrent with antiphospholipid syndrome, secondary to systemic lupus erythematosus. The patient was treated successfully by catheter-directed percutaneous thrombectomy, venous thrombolysis, and stent insertion, followed by oral anticoagulant therapy.
Keywords
Postthrombotic syndrome; Antiphospholipid syndrome; Lupus erythematosus; Systemic;
Citations & Related Records
연도 인용수 순위
  • Reference
1 May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957;8:419-427.   DOI   ScienceOn
2 Cockett FB, Thomas ML. The iliac compression syndrome. Br J Surg 1965;52:816-821.   DOI   ScienceOn
3 Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet 2010;376:1498-1509.   DOI   ScienceOn
4 Raffini L, Raybagkar D, Cahill AM, Kaye R, Blumenstein M, Manno C. May-Thurner syndrome (iliac vein compression) and thrombosis in adolescents. Pediatr Blood Cancer 2006; 47:834-838.   DOI   ScienceOn
5 Sharma R, Joshi W. A case of May-Thurner syndrome with antiphospholipid antibody syndrome. Conn Med 2008;72: 527-530.
6 Baron HC, Shams J, Wayne M. Iliac vein compression syndrome: a new method of treatment. Am Sung 2000;66: 653-655.
7 Knipp BS, Ferguson E, Williams DM, et al. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg 2007;46: 743-749.   DOI   ScienceOn
8 Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 2009;61:29-36.
9 Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol 2009;36:1195-1199.   DOI   ScienceOn
10 Binkert CA, Schoch E, Stuckmann G, et al. Treatment of pelvic venous spur (May-Thurner syndrome) with selfexpanding metallic endoprostheses. Cardiovasc Intervent Radiol 1998;21:22-26.   DOI   ScienceOn
11 Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-1302.   DOI   ScienceOn
12 Collaborative overview of randomised trials of antiplatelet therapy: III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients: Antiplatelet Trialists' Collaboration. BMJ 1994;308:235-246.   DOI   ScienceOn